Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-09

Clinical Trial Update: OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)

View source ↗

Summary

Non-interventional study update for OTIVACTO at RCV Vienna in COPD patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTIVACTO (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2019-01-09